TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10825325

Group type: EXPERIMENTAL
Intervention: 0.08% bupivacaine plus 2 microg/mL fentanyl (BF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.08% ropivacaine plus 2 microg/mL fentanyl (RF)
Number of subjects: 40
Study: 8851898

Group type: COMPARATOR
Intervention: Ambulatory Control (AC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Water Immersion at 80 degrees (WI80)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Water Immersion at 20 degrees (WI20)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chair Rest (CR)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Head-Down Bed Rest (BR)
Number of subjects: 6
Study: 7515429

Group type: EXPERIMENTAL
Intervention: 111In-CYT-103 immunoscintigraphy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 10
Study: 3311570

Group type: EXPERIMENTAL
Intervention: Acute ethanol consumption
Number of subjects: 0
Study: 29581659

Group type: EXPERIMENTAL
Intervention: Stabilization exercises with flexi-bar (FB)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Stabilization exercises (without FB)
Number of subjects: 27
Study: 27072546

Group type: EXPERIMENTAL
Intervention: High G tolerance group (H group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low G tolerance group (L group)
Number of subjects: 16
Study: 25351474

Group type: EXPERIMENTAL
Intervention: MEM 1414 (600 mg, twice daily orally for 7 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 22626489

Group type: EXPERIMENTAL
Intervention: Nonverbal response-card method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verbal responses (Control)
Number of subjects: 0
Study: 20729674

Group type: EXPERIMENTAL
Intervention: Peer mentoring strategy
Number of subjects: 0
Study: 17906853

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) - intravenous bolus of 100 mg preceding a continuous infusion of 10 mg/h (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (n = 15)
Number of subjects: 30
Study: 16425053

Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active immunisation against cocaine dependence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment in combination with cognitive behavioural therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vigabatrin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0
Study: 12810429

Group type: EXPERIMENTAL
Intervention: Lymecycline
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11021677

Group type: EXPERIMENTAL
Intervention: Standard Gamble
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Time Tradeoff
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rating Scale
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Utility Techniques
Number of subjects: 120
Study: 8799592

Group type: EXPERIMENTAL
Intervention: Prewarming by sitting for 30 min in a room at 30 degrees C
Number of subjects: 4

Group type: COMPARATOR
Intervention: No prewarming (exercise in winter)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Prewarming
Number of subjects: 4
Study: 1511475

Group type: EXPERIMENTAL
Intervention: Fruits and vegetables (mean 582 g/day) for 12 weeks
Number of subjects: 406
Study: 6217745

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 77

Group type: COMPARATOR
Intervention: Both groups (Acupuncture and Placebo)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Initial pain severity
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Psychotropic drug intake
Number of subjects: 77
Study: 29512356

Group type: EXPERIMENTAL
Intervention: M(3) program (Meals, Mindfulness, & Moving Forward)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 29905977

Group type: EXPERIMENTAL
Intervention: Inspiromatic
Number of subjects: 29

Group type: COMPARATOR
Intervention: Aerolizer
Number of subjects: 29
Study: 29798016

Group type: EXPERIMENTAL
Intervention: Tympanostomy tube insertion with adenoidectomy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Tympanostomy tube insertion only (Control)
Number of subjects: 126
Study: 25063905

Group type: EXPERIMENTAL
Intervention: OCP containing 30 mcg ethinyl estradiol (EE) plus 3 mg drospirenone for 3 months (Group 1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: OCP containing 30 mcg ethinyl estradiol (EE) plus 3 mg drospirenone for 3 months (Group 3)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No medication (Group 2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No medication (Group 4)
Number of subjects: 200
Study: 22775126

Group type: EXPERIMENTAL
Intervention: Musical training in depressed participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: No musical training in depressed participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Musical training in non-depressed participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No musical training in non-depressed participants
Number of subjects: 0
Study: 20619402

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 15
Study: 18372689

Group type: EXPERIMENTAL
Intervention: Daily 1 hr short radius centrifugation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (bed-rest without centrifugation)
Number of subjects: 0
Study: 15727947

Group type: EXPERIMENTAL
Intervention: D2-ORFa-Gly3Asp polymorphism in blood donors
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: D2-ORFa-Gly3Asp polymorphism in elderly men
Number of subjects: 505
Study: 12011773

Group type: EXPERIMENTAL
Intervention: Magnesium citrate (300 mg magnesium)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 9787979

Group type: EXPERIMENTAL
Intervention: Leukocyte interferon-alpha (1 MU three times weekly for one year)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Leukocyte interferon-alpha (3 MU three times weekly for a second cycle)
Number of subjects: 10
Study: 7667053

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg/day iv, divided into 4 daily doses for 4 days)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 56
Study: 2764271

Group type: EXPERIMENTAL
Intervention: Theophylline injection, 4 mg/kg body weight
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no theophylline)
Number of subjects: 60
Study: 734381

Group type: EXPERIMENTAL
Intervention: Osmic acid
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Radioactive yttrium
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Surgical synovectomy
Number of subjects: 66
Study: 31110103

Group type: EXPERIMENTAL
Intervention: Nurse care coordinator (NCC) led complex intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NCC training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Key process evaluation indicators
Number of subjects: 0
Study: 28102199

Group type: EXPERIMENTAL
Intervention: Simo decoction and acupuncture
Number of subjects: 590

Group type: COMPARATOR
Intervention: Chewing gum
Number of subjects: 590
Study: 25617215

Group type: EXPERIMENTAL
Intervention: Electronic monitoring device with audiovisual reminders enabled
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (audiovisual reminders disabled)
Number of subjects: 220
Study: 23261140

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Buspirone 10mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 22002264

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 108
Study: 18641035

Group type: EXPERIMENTAL
Intervention: NRTI-sparing regimen (NNRTI + boosted protease inhibitor)
Number of subjects: 117

Group type: COMPARATOR
Intervention: NRTI-containing regimen (PI/r + two NRTIs or NNRTI + two NRTIs)
Number of subjects: 117
Study: 16510640

Group type: EXPERIMENTAL
Intervention: Urinary antibiotic prophylaxis
Number of subjects: 236

Group type: COMPARATOR
Intervention: No urinary antibiotic prophylaxis (Control)
Number of subjects: 236
Study: 15510485

Group type: EXPERIMENTAL
Intervention: Topical mitomycin C (MMC) during trabeculectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no MMC)
Number of subjects: 0
Study: 11022835

Group type: EXPERIMENTAL
Intervention: Pinaverlum bromide (50 mg, t.i.d.)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Mebeverine (100 mg, t.i.d.)
Number of subjects: 91
Study: 9486028

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% once daily for 4 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: latanoprost 0.001% once daily for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison of latanoprost 0.005% and 0.001%
Number of subjects: 24
Study: 8354723

Group type: EXPERIMENTAL
Intervention: Flosser
Number of subjects: 35

Group type: COMPARATOR
Intervention: Finger flossing
Number of subjects: 35
Study: 3551827

Group type: EXPERIMENTAL
Intervention: Praziquantel at a dose of 75 mg/kg per day
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Praziquantel
Number of subjects: 74
Study: 31526286

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: PUVA (3 weekly sessions)
Number of subjects: 36
Study: 31591018

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 4 mg
Number of subjects: 182

Group type: COMPARATOR
Intervention: Intravenous (i.v.) dexamethasone 4 mg
Number of subjects: 182
Study: 29150377

Group type: EXPERIMENTAL
Intervention: Urgent ART (within 48 hours)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Post-stabilisation ART (in 7-14 days)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Urgent ART
Number of subjects: 191

Group type: COMPARATOR
Intervention: Post-stabilisation ART
Number of subjects: 191
Study: 27056882

Group type: EXPERIMENTAL
Intervention: Lower peak LA strain
Number of subjects: 357
Study: 25066385

Group type: EXPERIMENTAL
Intervention: Xylazine administered intravenously (i.v.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Xylazine administered intra-osseously (IO)
Number of subjects: 6
Study: 22310097

Group type: EXPERIMENTAL
Intervention: Robot-assisted (RO) pedicle screw implantation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Freehand (FH) conventional technique
Number of subjects: 60
Study: 20224274

Group type: EXPERIMENTAL
Intervention: Diet, energy-restricted by 30% from estimated energy expenditure (approximately 600 kcal/day) for 8 weeks
Number of subjects: 114
Study: 18343265

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) nasal spray (110 microg)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) nasal spray (200 microg)
Number of subjects: 127
Study: 16889545

Group type: EXPERIMENTAL
Intervention: Exercise and dietary counseling (ExD)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Adherers (Adh) to the intervention
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Nonadherers (Nadh) to the intervention
Number of subjects: 151
Study: 14671201

Group type: EXPERIMENTAL
Intervention: 10 microg melatonin infused i.v.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infused as the matching placebo
Number of subjects: 10
Study: 10968843

Group type: EXPERIMENTAL
Intervention: Endoscopic Doppler ultrasound (US) assessment of ulcers
Number of subjects: 52

Group type: COMPARATOR
Intervention: Endoscopic therapy
Number of subjects: 52
Study: 9053821

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 35
Study: 1594227

Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (27 eyes)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Photorefractive keratectomy (4 eyes)
Number of subjects: 31
Study: 6375490

Group type: EXPERIMENTAL
Intervention: 6-month regimen (isoniazid and rifampicin throughout, with ethambutol and pyrazinamide for the initial 2-month intensive phase)
Number of subjects: 601

Group type: COMPARATOR
Intervention: 12-month regimen (isoniazid and ethambutol throughout, supplemented by streptomycin during the first month)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: 6-month regimen (for patients with isoniazid-resistant strains)
Number of subjects: 601

Group type: COMPARATOR
Intervention: 12-month regimen (for patients with isoniazid-resistant strains)
Number of subjects: 601
Study: 29355046

Group type: EXPERIMENTAL
Intervention: 8-week hatha yoga intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 40
Study: 27670577

Group type: EXPERIMENTAL
Intervention: Short-course antibiotics (4 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-course antibiotics (duration not specified)
Number of subjects: 0
Study: 25596054

Group type: EXPERIMENTAL
Intervention: Flutamide-combined androgen blockade therapy (F-CAB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: LH-RH monotherapy
Number of subjects: 0
Study: 22652371

Group type: EXPERIMENTAL
Intervention: 100 mg dl-α-tocopheryl acetate (VE1)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 200 mg dl-α-tocopheryl acetate (VE2)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 300 mg dl-α-tocopheryl acetate (VE3)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 180
Study: 20444744

Group type: EXPERIMENTAL
Intervention: PRO 2000 gel 0.5%
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: PRO 2000 gel 2%
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 180

Group type: COMPARATOR
Intervention: Condom use only
Number of subjects: 180
Study: 18517084

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate, 110 microg once daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 16096220

Group type: EXPERIMENTAL
Intervention: GRAIDS software intervention with trained lead clinician
Number of subjects: 45

Group type: COMPARATOR
Intervention: Educational session and clinical guidelines for comparison practices
Number of subjects: 45
Study: 11872282

Group type: EXPERIMENTAL
Intervention: Once-daily thoracic radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice-daily thoracic radiation
Number of subjects: 0
Study: 10442374

Group type: EXPERIMENTAL
Intervention: UFT plus cisplatin with concurrent radiotherapy
Number of subjects: 17
Study: 8631075

Group type: EXPERIMENTAL
Intervention: Chinese herb-burn-incense
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine air sterilization methods (ultraviolet radiator, formaldehyde, lactiacid method)
Number of subjects: 0
Study: 2185625

Group type: EXPERIMENTAL
Intervention: 1.0 g glucose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.9 g uncooked cornstarch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.0 g glucose followed 20 min later by 1.75 g fructose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.9 g uncooked cornstarch followed 20 min later by 1.75 g fructose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water followed 20 min later by 1.75 g fructose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urinary chromium excretion
Number of subjects: 20
Study: 7396141

Group type: EXPERIMENTAL
Intervention: Droperidol 150 microgram/kg intravenously before anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 20
Study: 31712987

Group type: EXPERIMENTAL
Intervention: Early preventive measures including an early nephrology review applied to high risk patients
Number of subjects: 206

Group type: COMPARATOR
Intervention: Observation arm (no early preventive measures)
Number of subjects: 206
Study: 31142519

Group type: EXPERIMENTAL
Intervention: Cervical manipulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maximal neck rotation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cervical manipulation and maximal neck rotation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neutral neck position
Number of subjects: 20
Study: 27918927

Group type: EXPERIMENTAL
Intervention: Meatballs with 3% and 6% dietary fibre from rye bran
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Meatballs with 3% and 6% dietary fibre from pea fibre
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (meatballs without added fibre)
Number of subjects: 27
Study: 25921600

Group type: EXPERIMENTAL
Intervention: Curcumin (150 mg, theracurmin)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 14
Study: 23358161

Group type: EXPERIMENTAL
Intervention: PEG hydrogel dural sealant capping
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention (Control Group A)
Number of subjects: 10
Study: 21294635

Group type: EXPERIMENTAL
Intervention: Healthy Online Self-helping Center (HOSC) in laboratory environment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Healthy Online Self-helping Center (HOSC) in natural environment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Noninteractive program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 18191483

Group type: EXPERIMENTAL
Intervention: 12-lead electrocardiogram (ECG) patterns: ST-elevation ≥0.5 mm in lead aVL or any ST-elevation in lead aVR with precordial ST-segment elevation in at least two contiguous leads (including V2, V3, or V4)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: ECG or angiographic signs of lesion proximality
Number of subjects: 146
Study: 17261575

Group type: EXPERIMENTAL
Intervention: Day 3 blastomere biopsy, day 5 transfer (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Day 5 trophectoderm biopsy, day 6 transfer (Group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 20
Study: 14750002

Group type: EXPERIMENTAL
Intervention: Sweetened matrix formulation of OTFC (200 microg fentanyl)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Compressed powder formulation of OTFC (200 microg fentanyl)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11837468

Group type: EXPERIMENTAL
Intervention: Glibenclamide (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gliclazide (Group II)
Number of subjects: 50
Study: 9926788

Group type: EXPERIMENTAL
Intervention: Modified laparoscopic intraperitoneal onlay mesh herniorrhaphy (IPOM) using a meshed expanded polytetrafluorethylene (ePTFE) soft tissue patch
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional anterior inguinal herniorrhaphy (CH)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Modified laparoscopic intraperitoneal onlay mesh herniorrhaphy (IPOM)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 7803737

Group type: EXPERIMENTAL
Intervention: Bard bubble oxygenator H1700
Number of subjects: 500

Group type: COMPARATOR
Intervention: Bard membrane oxygenator HF5700
Number of subjects: 500
Study: 3407893

Group type: EXPERIMENTAL
Intervention: modified neuroleptanesthesia with midazolam, fentanyl, and vecuronium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: isoflurane anesthesia with vecuronium relaxation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 20
Study: 31094428

Group type: EXPERIMENTAL
Intervention: Revised WIC Food Package (including more whole grains, fruits, vegetables, and low-fat milk)
Number of subjects: 1454

Group type: COMPARATOR
Intervention: Control group (non-recipients)
Number of subjects: 1454
Study: 28832197

Group type: EXPERIMENTAL
Intervention: Bilateral views without training
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Bilateral views with training
Number of subjects: 82

Group type: COMPARATOR
Intervention: Unilateral views without training
Number of subjects: 82

Group type: COMPARATOR
Intervention: Unilateral views with training
Number of subjects: 82
Study: 25819480

Group type: EXPERIMENTAL
Intervention: Diabetes regimen distress (RD) intervention
Number of subjects: 392

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 392
Study: 23804544

Group type: EXPERIMENTAL
Intervention: OLD-FRAME: choose which item is 'older'
Number of subjects: 0

Group type: COMPARATOR
Intervention: NO-FRAME: choose which item is 'correct'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hierarchy recall accuracy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional awareness scores
Number of subjects: 0
Study: 21700755

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 44
Study: 19654918

Group type: EXPERIMENTAL
Intervention: Coarse concentrated ambient particles (CAPs)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 14
Study: 16756416

Group type: COMPARATOR
Intervention: Transdermal nicotine (TN) 0 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 7 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 21 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 42 mg
Number of subjects: 128
Study: 14770397

Group type: EXPERIMENTAL
Intervention: Tissue Harmonic Imaging (THI)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Fundamental Frequency Ultrasound (FFU)
Number of subjects: 71
Study: 11710925

Group type: EXPERIMENTAL
Intervention: Ultraviolet B exposure prior to hepatitis B vaccination
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (no ultraviolet B exposure)
Number of subjects: 191
Study: 9509495

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8143465

Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin (20 mg/mL) for 18 hrs/day for 5 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline (placebo) for 18 hrs/day for 5 days
Number of subjects: 41